Bryceson, A; (2001) Current issues in the treatment of visceral leishmaniasis. Medical microbiology and immunology, 190 (1-2). pp. 81-4. ISSN 0300-8584 https://researchonline.lshtm.ac.uk/id/eprint/17707 Full text not available from this repository.

Lee, JS; Song, CH; Kim, CH; Kong, SJ; Shon, MH; Suhr, JW; Jung, SS; Lim, JH; Kim, HJ; Park, JK; +2 more... Paik, TH; Jo, EK; (2003) Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients. Medical microbiology and immunology, 192 (2). pp. 61-9. ISSN 0300-8584 DOI: https://doi.org/10.1007/s00430-002-0117-2 Full text not available from this repository.

Prabowo, SA; Gröschel, MI; Schmidt, ED; Skrahina, A; Mihaescu, T; Hastürk, S; Mitrofanov, R; Pimkina, E; Visontai, I; de Jong, B; +4 more... Stanford, JL; Cardona, PJ; Kaufmann, SH; van der Werf, TS; (2012) Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines. Medical microbiology and immunology, 202 (2). pp. 95-104. ISSN 0300-8584 DOI: https://doi.org/10.1007/s00430-012-0278-6 Full text not available from this repository.

Rose, A; Kay, E; Wren, BW; Dallman, MJ; (2011) The Campylobacter jejuni NCTC11168 capsule prevents excessive cytokine production by dendritic cells. Medical microbiology and immunology. ISSN 0300-8584 DOI: https://doi.org/10.1007/s00430-011-0214-1 Full text not available from this repository.

Sindermann, H; Croft, SL; Engel, KR; Bommer, W; Eibl, HJ; Unger, C; Engel, J; (2004) Miltefosine (Impavido): the first oral treatment against leishmaniasis. Medical microbiology and immunology. p. 173. ISSN 0300-8584 DOI: https://doi.org/10.1007/s00430-003-0201-2 Full text not available from this repository.